Innovative Breakthrough: Transgenic Cows as the Future of Insulin Production
Revolutionizing Diabetes Treatment: Transgenic Cow Insulin Production
Welcome to a new era in medical innovation where biotechnology, genetic energy meets healthcare to create groundbreaking solutions for diabetes management. Our feature story delves into the remarkable development of a transgenic cow that are revolutionizing diabetes treatment. These remarkable bovines are not your ordinary farm animals; they are at the heart of a biotechnological breakthrough that could change the lives of millions of people with diabetes by producing human insulin. Discover how this scientific breakthrough is paving the way for sustainable, cost-effective insulin production, ensuring a future where diabetes treatment is more accessible and affordable than ever before. Join us as we uncover the science, the process, and the potential of this cutting-edge research.
First, We have to know why Diabetes happens.
Diabetes is a condition where our body does not make insulin or does not have enough Insulin enough for our body. Diabetes is of 2 types Type 1 and Type 2. Insulin is a Hormone that checks the level of Glucose in the blood. It is made by the cells of the pancreas.
Scientists used to extract insulin from slaughtered animals such as pigs and cows.
However, our body often reacts allergically to these animal cells due to their origin. Therefore, biotechnology is now used to extract insulin from E.coli and yeast. However, researchers at the University of Illinois are working to produce insulin using cow's milk as it is a commonly consumed product in most households.
The researchers explain in their paper that they used special techniques to put human insulin genes into cow cells so that the cows produce milk containing human insulin. This milk can, in turn, make insulin for people.
According to Matt Wheeler, a professor of biotechnology and developmental biology at the University of Illinois and co-author of the study, the mammary gland is designed by Mother Nature as a protein factory with high efficiency. This natural system can be utilized to produce a protein that can potentially benefit hundreds of millions of people worldwide.
Curious about their process? Let's uncover the mystery behind it - how did they do it?
Wheeler collaborated with his friends in Brazil to conduct an experiment involving cow embryos. They inserted a part of human DNA that produces proinsulin, the forerunner to insulin, into 10 cow embryos. These embryos were then implanted into the wombs of normal cows. However, only one calf was born with the new gene.
Thanks to advanced genetic technology, they ensured that the human DNA only functioned in the mammary glands of the cows, which are responsible for producing milk. This allowed for the production of a specific protein, human insulin, to occur only in the mammary glands of the modified cows.
Then The researchers tried to impregnate the cow but the Regular methods were ineffective, so they induced lactation with hormones.
Despite not being pregnant, the lactating female produced a reduced amount of milk compared to her usual amount. However, upon analysis, it was discovered that the milk contained both human proinsulin and insulin, which was an unexpected finding.
The researchers aimed to produce proinsulin, refine it into insulin, and proceed from there. However, the cow was able to process it on her own. She produces approximately three times more biologically active insulin than proinsulin. Wheeler stated, "The mammary gland is truly a magical thing."
The insulin produced can now be used to effectively treat and manage diabetes in individuals. This breakthrough discovery offers new hope for those suffering from this condition, and presents a promising path towards a healthier and happier life.
Conclusion
As we conclude our exploration into the revolutionary world of biotechnology, it’s clear that the development of transgenic cows capable of producing human insulin marks a significant milestone in medical innovation. This advancement not only showcases the remarkable potential of genetic engineering but also offers a beacon of hope for millions affected by diabetes. The promise of sustainable and accessible insulin production through such scientific breakthroughs paves the way for a future where healthcare is more responsive to the needs of patients worldwide. As we continue to witness these incredible strides in medicine, one thing becomes certain: the horizon of medical possibilities is expanding, and with it, our capacity to tackle some of the most challenging health issues of our time.
Comments
Post a Comment